TI - Clinicopathological Characteristics of Patients with HR-Positive/HER2-Negative Metastatic Breast Cancer Experiencing Early Progression Within 6 Months of CDK4/6 Inhibitor Therapy
PT - Journal Article
DP - 2026
TA - EJMI
PG - 433-440
VI - 10
IP - 3
AID - 269433 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.269433
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(3): 433